Factors Affecting Virological Failure in Children Receiving First-Line Antiretroviral Therapy in Ethiopian Healthcare Facilities: A Retrospective Analysis
- PMID: 38765900
- PMCID: PMC11100487
- DOI: 10.2147/PHMT.S452150
Factors Affecting Virological Failure in Children Receiving First-Line Antiretroviral Therapy in Ethiopian Healthcare Facilities: A Retrospective Analysis
Abstract
Background: The causes of virological failure are poorly recognized and investigated. This study aimed to identify determinant factors of viral failure in children taking first-line ART at a randomly selected federal hospital in Addis Ababa, Ethiopia.
Methods: A facility-based unmatched case-control study was carried out from May 10, 2022, to July 20, 2022, G.C. among HIV-infected children on first-line antiretroviral therapy. There were 209 HIV-positive youngsters in the study's overall sample size, comprising 53 cases and 156 controls. Data was gathered by chart review using an organized checklist in English. The data were entered using Epi-data 4.2 and exported into SPSS version 24 for analysis. The relationship between each explanatory variable and the result variable was described using both bivariate and multivariate analysis. An adjusted odds ratio with 95% confidence intervals was conducted, and a p-value <0.05 was considered statistically significant.
Results: Being male (AOR= 4.504; 95% CI: 1.498, 13.539), duration on ART exceeding 47 months (AOR=40.6; 95% CI:9.571,172.222), fair and poor drug adherence (AOR=16.348; 95% CI:4.690,56.990), missed clinical appointments (AOR = 3.177; 95% CI: 1.100-9.174), and baseline WHO clinical stage 4 disease (AOR = 6.852; 95% CI: 1.540-30.49) were associated with an increased risk of virological failure. Conversely, a history of drug change and a CD4 count ranging from 250 to 500 cells/mm3 were significantly protective factors (AOR = 0.071; 95% CI: 0.024-0.214 and AOR=0.118; 95% CI: 0.030, 0.464, respectively).
Conclusion: Being male, duration on ART >47 months, fair and poor adherence, missed clinical appointments, and baseline WHO Stage 4 are factors that increase the odds of virological failure. History of ART Drug change and a CD4 count between 250 and 500 cells/mm3 are factors that decrease the odds of virological failure.
Keywords: Ethiopia; antiretroviral therapy; children; retrospective; virological failure.
© 2024 Desalegn et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
Determinants of Virological Failure Among HIV-Infected Children on First-Line Antiretroviral Therapy in West Gojjam Zone, Amhara Region, Ethiopia.HIV AIDS (Auckl). 2021 Dec 14;13:1035-1044. doi: 10.2147/HIV.S334067. eCollection 2021. HIV AIDS (Auckl). 2021. PMID: 34934365 Free PMC article.
-
Magnitude and associated factors of virological failure among children on ART in Bahir Dar Town public health facilities, Northwest Ethiopia: a facility based cross-sectional study.Ital J Pediatr. 2021 Apr 6;47(1):84. doi: 10.1186/s13052-021-01030-7. Ital J Pediatr. 2021. PMID: 33823890 Free PMC article.
-
Determinants of first-line antiretroviral treatment failure among adult patients on treatment in Mettu Karl Specialized Hospital, South West Ethiopia; a case control study.PLoS One. 2021 Oct 22;16(10):e0258930. doi: 10.1371/journal.pone.0258930. eCollection 2021. PLoS One. 2021. PMID: 34679085 Free PMC article.
-
Determinants of Virological Failure Among Patients on First-line Antiretroviral Therapy in Central Oromia, Ethiopia: A Case-Control Study.HIV AIDS (Auckl). 2020 Dec 14;12:931-939. doi: 10.2147/HIV.S281672. eCollection 2020. HIV AIDS (Auckl). 2020. PMID: 33363411 Free PMC article.
-
Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia.AIDS Res Ther. 2020 Jul 10;17(1):39. doi: 10.1186/s12981-020-00294-z. AIDS Res Ther. 2020. PMID: 32650796 Free PMC article.
References
-
- Approach PH, On CG. Guidelines HIV prevention, testing, treatment, service delivery and monitoring; 2021. - PubMed
-
- World Health Organization. Global HIV, hepatitis and STIs programmes. HIV data Stat Geneva WHO; 2020.;
-
- World Health Organization. Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. World Health Organization; 2015. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials